Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital, Ghent, Belgium.
Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.
J Bone Miner Res. 2018 Feb;33(2):261-268. doi: 10.1002/jbmr.3303. Epub 2017 Nov 17.
Biochemical markers of bone turnover are higher in young adult men than in middle-aged men or young adult women. Nonetheless, little is known about the determinants and clinical significance hereof. The present study examined determinants of serum bone turnover markers in men around peak bone mass age, and explored whether bone turnover at this age predicts subsequent changes in bone mass. We used cross-sectional and longitudinal data from 973 and 428 healthy men, respectively, aged 25 to 45 years at baseline, including baseline procollagen type I amino-terminal propeptide (P1NP), osteocalcin, and C-terminal telopeptide of type I collagen (CTX) from fasting serum samples, baseline questionnaire-assessed physical activity levels, and baseline and follow-up dual-energy X-ray absorptiometry-derived areal bone mineral density (aBMD) and body composition. Mean follow-up time was 12.4 ± 0.4 years. At baseline, all bone turnover markers were inversely associated with total body fat mass (β ≤ -0.20, p < 0.001), and positively with physical activity during sports activities (β ≥ 0.09, p ≤ 0.003), and, albeit not independently from fat mass, total body lean mass (β ≥ 0.20, p ≤ 0.003). Mean annual aBMD changes in the longitudinal cohort were -0.19% ± 0.24% at the total body, -0.14% ± 0.42% at the spine, -0.49% ± 0.47% at the femoral neck, and -0.25% ± 0.37% at the total hip (all p < 0.001). Higher bone turnover markers at baseline were associated with larger decreases in aBMD at all measurement sites (β ≤ -0.08, p ≤ 0.081 for P1NP; β ≤ -0.16, p ≤ 0.002 for osteocalcin; and β ≤ -0.21, p < 0.001 for CTX). In conclusion, our findings show that sports activities and body composition, primarily fat mass, are the main identified determinants of bone turnover in men around peak bone mass age. Further, bone turnover at this age is an important determinant of subsequent changes in bone mass, with higher levels of bone turnover markers being associated with greater decreases in aBMD. © 2017 American Society for Bone and Mineral Research.
骨转换的生化标志物在年轻成年男性中高于中年男性或年轻成年女性。尽管如此,目前对于其决定因素和临床意义还知之甚少。本研究检测了在骨峰值年龄的男性中血清骨转换标志物的决定因素,并探讨了该年龄段的骨转换是否可以预测随后的骨量变化。我们使用了分别来自 973 名和 428 名健康男性的横断面和纵向数据,这些男性在基线时的年龄为 25 至 45 岁,包括空腹血清样本中的基线前胶原 I 氨基端前肽(P1NP)、骨钙素和 I 型胶原 C 端肽(CTX),基线问卷评估的身体活动水平,以及基线和随访的双能 X 射线吸收法测定的面积骨密度(aBMD)和身体成分。平均随访时间为 12.4 ± 0.4 年。在基线时,所有骨转换标志物均与全身脂肪量呈负相关(β ≤ -0.20,p < 0.001),与运动时的身体活动呈正相关(β ≥ 0.09,p ≤ 0.003),尽管与脂肪量无独立相关性,但与全身瘦体量呈正相关(β ≥ 0.20,p ≤ 0.003)。纵向队列的平均年 aBMD 变化为全身-0.19% ± 0.24%,脊柱-0.14% ± 0.42%,股骨颈-0.49% ± 0.47%,总髋部-0.25% ± 0.37%(均 p < 0.001)。基线时较高的骨转换标志物与所有测量部位的 aBMD 下降更大相关(β ≤ -0.08,p ≤ 0.081 用于 P1NP;β ≤ -0.16,p ≤ 0.002 用于骨钙素;β ≤ -0.21,p < 0.001 用于 CTX)。总之,我们的研究结果表明,运动和身体成分,主要是脂肪量,是男性在骨峰值年龄时骨转换的主要决定因素。此外,该年龄段的骨转换是随后骨量变化的一个重要决定因素,较高的骨转换标志物水平与 aBMD 的较大下降相关。